Literature DB >> 19099294

Cognitive and psychomotor effects in males after smoking a combination of tobacco and cannabis containing up to 69 mg delta-9-tetrahydrocannabinol (THC).

Claudine C Hunault1, Tjeert T Mensinga, Koen B E Böcker, C Maarten A Schipper, Maaike Kruidenier, Marianne E C Leenders, Irma de Vries, Jan Meulenbelt.   

Abstract

RATIONALE: Delta(9)-Tetrahydrocannabinol (THC) is the main active constituent of cannabis. In recent years, the average THC content of some cannabis cigarettes has increased up to approximately 60 mg per cigarette (20% THC cigarettes). Acute cognitive and psychomotor effects of THC among recreational users after smoking cannabis cigarettes containing such high doses are unknown.
OBJECTIVES: The objective of this study was to study the dose-effect relationship between the THC dose contained in cannabis cigarettes and cognitive and psychomotor effects for THC doses up to 69.4 mg (23%).
MATERIALS AND METHODS: This double-blind, placebo-controlled, randomised, four-way cross-over study included 24 non-daily male cannabis users (two to nine cannabis cigarettes per month). Participants smoked four cannabis cigarettes containing 0, 29.3, 49.1 and 69.4 mg THC on four exposure days.
RESULTS: The THC dose in smoked cannabis was linearly associated with a slower response time in all tasks (simple reaction time, visuo-spatial selective attention, sustained attention, divided attention and short-term memory tasks) and motor control impairment in the motor control task. The number of errors increased significantly with increasing doses in the short-term memory and the sustained attention tasks. Some participants showed no impairment in motor control even at THC serum concentrations higher than 40 ng/mL. High feeling and drowsiness differed significantly between treatments.
CONCLUSIONS: Response time slowed down and motor control worsened, both linearly, with increasing THC doses. Consequently, cannabis with high THC concentrations may be a concern for public health and safety if cannabis smokers are unable to titrate to a high feeling corresponding to a desired plasma THC level.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19099294     DOI: 10.1007/s00213-008-1440-0

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  28 in total

1.  The risks for late adolescence of early adolescent marijuana use.

Authors:  J S Brook; E B Balka; M Whiteman
Journal:  Am J Public Health       Date:  1999-10       Impact factor: 9.308

Review 2.  Antidepressants and driver impairment: empirical evidence from a standard on-the-road test.

Authors:  Johannes G Ramaekers
Journal:  J Clin Psychiatry       Date:  2003-01       Impact factor: 4.384

3.  Acute marijuana effects on human risk taking.

Authors:  Scott D Lane; Don R Cherek; Oleg V Tcheremissine; Lori M Lieving; Cythia J Pietras
Journal:  Neuropsychopharmacology       Date:  2005-04       Impact factor: 7.853

4.  Behavioural and biochemical evidence for interactions between Delta 9-tetrahydrocannabinol and nicotine.

Authors:  Emmanuel Valjent; Jennifer M Mitchell; Marie-Jo Besson; Jocelyne Caboche; Rafael Maldonado
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

5.  Effects of acute smoked marijuana on complex cognitive performance.

Authors:  C L Hart; W van Gorp; M Haney; R W Foltin; M W Fischman
Journal:  Neuropsychopharmacology       Date:  2001-11       Impact factor: 7.853

6.  High-potency marijuana impairs executive function and inhibitory motor control.

Authors:  Johannes G Ramaekers; Gerhold Kauert; Peter van Ruitenbeek; Eef L Theunissen; Erhard Schneider; Manfred R Moeller
Journal:  Neuropsychopharmacology       Date:  2006-03-29       Impact factor: 7.853

7.  Cognitive and subjective dose-response effects of acute oral Delta 9-tetrahydrocannabinol (THC) in infrequent cannabis users.

Authors:  H Valerie Curran; Catherine Brignell; Sally Fletcher; Paul Middleton; John Henry
Journal:  Psychopharmacology (Berl)       Date:  2002-07-23       Impact factor: 4.530

8.  Comparative effects of alcohol and marijuana on mood, memory, and performance.

Authors:  S J Heishman; K Arasteh; M L Stitzer
Journal:  Pharmacol Biochem Behav       Date:  1997-09       Impact factor: 3.533

9.  Potency of delta 9-THC and other cannabinoids in cannabis in England in 2005: implications for psychoactivity and pharmacology.

Authors:  David J Potter; Peter Clark; Marc B Brown
Journal:  J Forensic Sci       Date:  2008-01       Impact factor: 1.832

10.  Blunted psychotomimetic and amnestic effects of delta-9-tetrahydrocannabinol in frequent users of cannabis.

Authors:  Deepak Cyril D'Souza; Mohini Ranganathan; Gabriel Braley; Ralitza Gueorguieva; Zoran Zimolo; Thomas Cooper; Edward Perry; John Krystal
Journal:  Neuropsychopharmacology       Date:  2008-01-09       Impact factor: 7.853

View more
  37 in total

Review 1.  The why behind the high: determinants of neurocognition during acute cannabis exposure.

Authors:  Johannes G Ramaekers; Natasha L Mason; Lilian Kloft; Eef L Theunissen
Journal:  Nat Rev Neurosci       Date:  2021-05-27       Impact factor: 34.870

Review 2.  Lower-Risk Cannabis Use Guidelines: A Comprehensive Update of Evidence and Recommendations.

Authors:  Benedikt Fischer; Cayley Russell; Pamela Sabioni; Wim van den Brink; Bernard Le Foll; Wayne Hall; Jürgen Rehm; Robin Room
Journal:  Am J Public Health       Date:  2017-06-23       Impact factor: 9.308

Review 3.  Marijuana Legalization: Impact on Physicians and Public Health.

Authors:  Samuel T Wilkinson; Stephanie Yarnell; Rajiv Radhakrishnan; Samuel A Ball; Deepak Cyril D'Souza
Journal:  Annu Rev Med       Date:  2015-10-19       Impact factor: 13.739

Review 4.  Cannabis in sport: anti-doping perspective.

Authors:  Marilyn A Huestis; Irene Mazzoni; Olivier Rabin
Journal:  Sports Med       Date:  2011-11-01       Impact factor: 11.136

Review 5.  Adolescent cannabis use and psychosis: epidemiology and neurodevelopmental models.

Authors:  Daniel T Malone; Matthew N Hill; Tiziana Rubino
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

Review 6.  Cannabis use among U.S. adolescents in the era of marijuana legalization: a review of changing use patterns, comorbidity, and health correlates.

Authors:  Christopher J Hammond; Aldorian Chaney; Brian Hendrickson; Pravesh Sharma
Journal:  Int Rev Psychiatry       Date:  2020-02-06

7.  Cognitive motor deficits in cannabis users.

Authors:  Shikha Prashad; Francesca M Filbey
Journal:  Curr Opin Behav Sci       Date:  2017-02

8.  Neuropsychological deficits associated with cannabis use in young adults.

Authors:  Jon E Grant; Samuel R Chamberlain; Liana Schreiber; Brian L Odlaug
Journal:  Drug Alcohol Depend       Date:  2011-09-14       Impact factor: 4.492

9.  Altered brain activation during visuomotor integration in chronic active cannabis users: relationship to cortisol levels.

Authors:  George R King; Thomas Ernst; Weiran Deng; Andrew Stenger; Rachael M K Gonzales; Helenna Nakama; Linda Chang
Journal:  J Neurosci       Date:  2011-12-07       Impact factor: 6.167

10.  Effects of a novel CB1 agonist on visual attention in male rats: role of strategy and expectancy in task accuracy.

Authors:  Rikki L A Miller; Ganesh A Thakur; William N Stewart; Joshua P Bow; Shama Bajaj; Alexandros Makriyannis; Peter J McLaughlin
Journal:  Exp Clin Psychopharmacol       Date:  2013-10       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.